Akcea Therapeutics, Inc.

CIK 1662524 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akcea Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 10, 2020SC 13G/A0000315066-20-001917
Oct 23, 202015-12B0001193125-20-274919
Oct 14, 202040000899243-20-028167
Oct 13, 202040001209191-20-054604
Oct 13, 202040001209191-20-054616
Oct 13, 202040001209191-20-054611
Oct 13, 2020SC 13E3/A0001193125-20-268016
Oct 13, 202040001209191-20-054612
Oct 13, 2020S-8 POS0001193125-20-268035
Oct 13, 2020SC 13D/A0001193125-20-268022
Oct 13, 20208-K0001193125-20-268019
Oct 13, 202040001209191-20-054613
Oct 13, 2020SC 14D9/A0001193125-20-268015
Oct 13, 202040001209191-20-054607
Oct 13, 202025-NSE0001354457-20-000579
Oct 13, 2020SC 13G/A0000315066-20-001814
Oct 13, 2020SC TO-T/A0001193125-20-268013
Oct 13, 202040001209191-20-054622
Oct 13, 2020S-8 POS0001193125-20-268033
Oct 13, 2020S-8 POS0001193125-20-268034
Oct 13, 2020S-8 POS0001193125-20-268031
Oct 13, 202040001209191-20-054614
Oct 13, 2020S-8 POS0001193125-20-268028
Oct 13, 202040001209191-20-054615
Oct 13, 202040001209191-20-054610